Skip to main content

Table 2 Normalized absorbed doses per injected activity (in mGy/MBq) in tumors and organs at risk for each patient, and their average over the entire dataset. The standard deviation (± SD) and the minimum and maximum normalized doses are also reported. Additionally, the absolute mean (± SD), minimum, and maximum absorbed doses are reported

From: Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans

Patient no.

Tumor

Liver

Lungs

Stomach

Spleen

Kidneys

1

13.92

2.41

0.09

0.58

0.88

0.36

2

5.71

1.37

0.20

0.63

0.45

0.31

3

2.56

0.99

N/A

0.26

0.36

N/A

4

8.99

1.19

0.11

0.32

0.14

0.25

5

31.94

2.39

0.16

0.20

0.12

0.10

6

5.46

1.24

0.06

0.29

0.25

0.22

7a

3.65

1.98

0.07

0.13

0.53

0.45

7b

9.17

2.31

0.09

0.05

0.33

0.24

8

9.99

0.86

0.11

0.31

0.46

0.18

9

14.75

1.03

0.08

0.53

0.15

0.13

10

53.83

3.78

0.13

0.45

0.68

0.48

11

2.32

0.48

0.02

0.77

0.09

N/A

12

4.76

1.69

0.17

0.20

0.73

0.17

13

162.49

7.82

0.13

0.16

0.21

N/A

Mean ± SD

23.5 ± 40.8

2.12 ± 1.78

0.11 ± 0.05

0.35 ± 0.20

0.38 ± 0.24

0.26 ± 0.12

Min

2.32

0.48

0.02

0.05

0.09

0.10

Max

162.49

3.78

0.20

0.77

0.88

0.48

Absolute mean [Gy]

50.4 ± 66.4

6.1 ± 4.0

0.3 ± 0.2

1.1 ± 0.9

1.4 ± 1.1

0.9 ± 0.7

Absolute min [Gy]

4.0

0.8

0.03

0.3

0.2

0.2

Absolute max [Gy]

266.0

12.8

1.1

3.8

3.0

2.4